相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Risk factors for financial toxicity in patients with gynecologic cancer
Emeline M. Aviki et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer
Ana Oaknin et al.
EUROPEAN JOURNAL OF CANCER (2022)
Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017
Ashish A. Deshmukh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Tisotumab vedotin (TV) plus carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study
I. B. Vergote et al.
ANNALS OF ONCOLOGY (2021)
Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials
Soumya J. Niranjan et al.
CANCER (2020)
Cervical cancer in low and middle-income countries
Rodney Hull et al.
ONCOLOGY LETTERS (2020)
Rural-Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010-2014
Lulu Yu et al.
PREVENTING CHRONIC DISEASE (2019)
Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States
Wonsuk Yoo et al.
PLOS ONE (2017)